Immunoassay Market
Immunoassay Market - Global Industry Assessment & Forecast
#
Pages:
140
2022
Jul - 2023
VMR-1360
Segments Covered
By
Product Reagents & Kits, Analyzers, Software, Services
-
By
Technology Chemiluminescent Immunoassay, Radio Immunoassay, Enzyme-Linked Immunoassay, Fluorescence Immunoassay, Other Technologies
-
By
Specimen Blood, Saliva, Urine, Other Specimens
-
By
Application Clinical Diagnostics, Research Applications, Other Applications
-
By
End User Hospitals & Diagnostic Laboratories, Research & Academic Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 29438.72 Million |
 Revenue 2030:
|
USD 47993.78 Million |
 Revenue CAGR
(2023 - 2030): |
6.3% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
| Sr. No. | Offering | Report Coverage |
| 1. | Market Size | In terms of Revenue (USD Million) |
| 2. | Historic Data | 2017 to 2021 |
| 3. | Forecast Data | 2023 to 2030 |
| 4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
| 5. | Market Attractiveness Analysis | Yes |
| 6. | Segment Analysis | Maximum Segments |
| 7. | Regional Coverage | 5 Regions |
| 8. | Country Coverage | Top 22 Countries |
| 9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
| 10. | Porter’s Five Forces Analysis | Yes. |
| 11. | Value Chain Analysis | Yes |
| 12. | PEST Analysis | Yes |
| 13. | Regulatory Landscape | Yes |
| 14. | Technology Landscape | Yes |
| 15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
| 16. | Top startups to watch out for | Yes |
| 17. | Top 3 Trends to Watch | Yes |
| 18. | Top 3 Strategies Followed by Major Players | Yes |
| 19. | Top 3 Predictions by Vantage Market Research | Yes |
| 20. | Discussion Guide | Yes |
| 21. | Key Primary Respondents - VERBATIM | Yes |
| 22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
| 23. | Others/Miscellaneous | |
FAQ
Frequently Asked Question
What is the global demand for Immunoassay in terms of revenue?
-
The global Immunoassay valued at USD 29438.72 Million in 2022 and is expected to reach USD 47993.78 Million in 2030 growing at a CAGR of 6.3%.
Which are the prominent players in the market?
-
The prominent players in the market are Danaher (U.S.), Thermo Fisher Scientific (U.S.), Abbott Laboratories (U.S.), Roche (Switzerland), Siemens Healthineer (Germany), Quidel (U.S.), DiaSorin (Italy), bioMérieux (France), Bio-Rad Laboratories (U.S.), Ortho Clinical Diagnostics (U.S.), PerkinElmer (U.S.), Becton Dickinson & Company (U.S.), Sysmex (Japan), Agilent Technologies (U.S.), Mindray (China), QIAGEN (Netherlands), Merk KGaA (Germany), Bio-Techne (U.S.), Cellabs (Australia), Abnova Corporation (Taiwan), J. Mitra & Co. Pvt. Ltd. (India), Tosoh Corporation (Japan), Cell Sciences (U.S.), Enzo Biochem Inc.(U.S.), Creative Diagnostics (U.S.), Boster Biological Technology (U.S.), Elabscience Inc. (U.S.), WAK-Chemie Medical GmbH (Germany), Sera Care (U.S.), Epitope Diagnostics Inc. (U.S.), Kamiya Biomedical Company (U.S.) Gyros Protein Technologies (Sweden).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 6.3% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Immunoassay include
- introduction of advanced technology
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Immunoassay in 2022.
